Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods

References

• Woodbury D, Schwarz E, Prockop D, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364–70
   PubMed Web of Science ®Google Scholar
• Wakitani S, Saito T, Caplan A. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417–26
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–22
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–41
   PubMed Web of Science ®Google Scholar
• Van Damme A, Vanden DT, Collen D, et al. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195–209
   PubMedGoogle Scholar
• Van Damme A, Vanden DT, Collen D, et al. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195–209
   PubMedGoogle Scholar
• Reiser J, Zhang XY, Hemenway CS, et al. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005; 5: 1571–84
   PubMed Web of Science ®Google Scholar
• Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289: F31–42
   PubMed Web of Science ®Google Scholar
• Kurozumi K, Nakamura K, Tamiya T, et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004; 9: 189–97
   PubMed Web of Science ®Google Scholar
• Duan H, Wu C, Wu D, et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 2003; 8: 467–74
   PubMed Web of Science ®Google Scholar
• Van Damme A, Vanden DT, Collen D, et al. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195–209
   PubMedGoogle Scholar
• Van Damme A, Vanden DT, Collen D, et al. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195–209
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Rubin C, Hirsch A, Fung C, et al. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 1978; 253: 7570–8
   PubMed Web of Science ®Google Scholar
• Kunter U, Rong S, Boor P, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007; 18: 1754–64
   PubMed Web of Science ®Google Scholar
• Kicic A, Shen WY, Wilson AS, et al. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci 2003; 23: 7742–9
   PubMed Web of Science ®Google Scholar
• Yang JF, Zhou WW, Tang T, et al. Transfection of human VEGF165 gene into bone marrow mesenchymal stem cells in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006; 31: 313–8
   Google Scholar
• Yang J, Zhou W, Zheng W, et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007; 107: 17–29
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–7
   PubMed Web of Science ®Google Scholar
• Kunter U, Rong S, Boor P, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007; 18: 1754–64
   PubMed Web of Science ®Google Scholar
• Kicic A, Shen WY, Wilson AS, et al. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci 2003; 23: 7742–9
   PubMed Web of Science ®Google Scholar
• Yang JF, Zhou WW, Tang T, et al. Transfection of human VEGF165 gene into bone marrow mesenchymal stem cells in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006; 31: 313–8
   Google Scholar
• Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 2005; 7: E61–77
   PubMed Web of Science ®Google Scholar
• Hoelters J, Ciccarella M, Drechsel M, et al. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 2005; 7: 718–28
   PubMed Web of Science ®Google Scholar
• Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 2001; 46: 187–203
   PubMed Web of Science ®Google Scholar
• Jo J, Nagaya N, Miyahara Y, et al. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 2007; 13: 313–22
   PubMedGoogle Scholar
• Koynova R, Tarahovsky YS, Wang L, et al. Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta 2007; 1768: 375–86
   Google Scholar